Bellingham, MA, United States of America

Todd B Sells

This inventor holds 20 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Cancer Therapeutics. Top assignees: Millennium Pharmaceuticals Limited, Bayer Corporation, Millenium Pharmaceuticals, Inc.. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Todd B Sells. Retrieved from https://idiyas.com/inventor/todd-b-sells

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 90.0


 

Average Co-Inventor Count = 4.8

ph-index = 10

Forward Citations = 204(Granted Patents)


Location History:

  • Southborough, MA (US) (2014 - 2017)
  • Bellingham, MA (US) (2002 - 2024)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aurora Kinase Inhibitors
NEDD8-Activating Enzyme
Mitotic Progression
Heteroaryls
Acridinium Compounds
Pyridobenzazepine
Nucleic Acid Probes
Oligonucleotide Probes
Homogeneous Assays
Compounds
Fluorescent Labels
20 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Todd B Sells in Cancer Treatment

Introduction

Todd B Sells, an accomplished inventor based in Bellingham, MA, has made significant contributions to the field of cancer treatment with his innovative inventions. With a remarkable portfolio of 20 patents, Sells has developed compounds and methods that aim to combat cancer effectively. His dedication to advancing medical science is evident through his research and the applications of his inventions.

Latest Patents

Among Todd B Sells' latest patents are the inventions related to Aurora kinase inhibitors aimed at inhibiting mitotic progression. The first of these patents details compounds and methods for the treatment of cancer, specifically potent inhibitors of Aurora A kinase. This invention encompasses pharmaceutical compositions comprising these compounds and outlines methods for their use in cancer treatment. In the second patent, Sells further expands on the formulation of compounds targeting Aurora kinase and their application in medical therapies designed to inhibit mitotic progression, showcasing his commitment to innovative cancer therapies.

Career Highlights

Throughout his career, Todd B Sells has collaborated with notable companies such as Millennium Pharmaceuticals Limited and Bayer Corporation. His experience in these organizations has greatly contributed to his expertise in drug development and cancer research, providing a solid foundation for his innovative work.

Collaborations

In his pursuit of advancing cancer treatments, Sells has worked alongside esteemed colleagues such as Stephen G Stroud and Christopher F Claiborne. These collaborations illustrate the importance of teamwork in the sciences, facilitating the exchange of ideas and fostering an environment conducive to innovation.

Conclusion

In summary, Todd B Sells stands out as a leading inventor in the area of cancer treatment. His significant contributions through his patents highlight his dedication to medical advancements and innovative methodologies. As research progresses, Sells' inventions may play a crucial role in shaping the future of cancer therapeutics, offering hope to patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…